Atezolizumab Plus CArboplatin Plus Nab-paclitaxel
NCT05266937
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
49
Enrollment
OTHER
Sponsor class
Conditions
Metastatic Breast Cancer
Triple Negative Breast Cancer
PD-L1 Gene Mutation
Interventions
COMBINATION_PRODUCT:
Atezolizumab,Paclitaxel, Carboplatin
Sponsor
Consorzio Oncotech